Evidence map›Paper›PMID 31494770›Full record

ReviewCurrent cardiology reports2019

Is There a Safety Concern for Drug-Coated Balloons in Peripheral Arterial Disease?

Mohamed M Gad, Antonette K Karrthik, Ahmad A Mahmoud, Ahmed N Mahmoud

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Mohamed M GadDepartment of Cardiovascular Medicine, Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, OH, USA.
Antonette K KarrthikDepartment of Cardiovascular Medicine, Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, OH, USA.
Ahmad A MahmoudDepartment of Internal Medicine, University of Florida, Gainesville, FL, USA.
Ahmed N MahmoudDivision of Cardiology, University of Washington, Seattle, WA, USA. Ahmoud@UW.edu.
Cleveland Clinic · USCleveland Foundation · USSeattle University · USUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewDrug-coated balloons (DEB) and drug-eluting stents (DES) emerged as a tool to aid in lowering the rates of neointimal hyperplasia and target lesion restenosis following endovascular peripheral arterial disease (PAD) interventions. RECENT

findingsAlthough the initial trials comparing these devices with non-drug balloons and stents showed favorable results, more recent data raised concerns regarding the mid to long-term safety of these devices. In this review, we will discuss the evolution of endovascular therapy for PAD, with highlights regarding the recent debates on the long-term safety of the drug-coated devices for treatment of PAD.

Indexed as

Angioplasty, BalloonCoated Materials, BiocompatibleDrug-Eluting StentsCardiovascular AgentsConstriction, PathologicEndovascular ProceduresHumansPaclitaxelPeripheral Arterial DiseasePopliteal ArteryProsthesis DesignTreatment OutcomeCardiovascular AgentsCoated Materials, BiocompatiblePaclitaxelEndovascular therapyMortalityPaclitaxelPeripheral arterial disease

Identifiers

PMID31494770
OpenAlexW2971622810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.